Skip to main content
OpenTrials

Clinical trial condition

Rhabdomyosarcoma

Explore clinical trials studying Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.

186 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Rhabdomyosarcoma trial results

Completed

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

NCT03245151

Conditions
Central Nervous System Neoplasms, Disease Attributes, Glioma, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Miller Children's and Women's Hospital Long Beach, California, United States
View all 50 locations
View Trial Details
Completed

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

NCT00053794

Conditions
Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +41 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • British Columbia Cancer Agency - Vancouver Island Cancer Centre Vancouver, British Columbia, Canada
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
View Trial Details
Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

NCT00354835

Conditions
Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Botryoid-Type Embryonal Rhabdomyosarcoma, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 226 locations
View Trial Details
Completed

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

NCT00876031

Conditions
Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Krankenhaus der Stadt Dornbirn Dornbirn, Austria
  • Universitätsklinik für Kinder- und Jugendheilkunde Graz, Austria
  • Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria
  • Landeskrankenhaus Klagenfurt, Austria
View all 87 locations
View Trial Details
Completed

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

NCT03441360

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

NCT03245450

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • Hopitaux de La Timone Marseille, Bouches-du-Rhône, France
  • Centre Oscar Lambret Lille, Nord, France
  • Centre Léon Berard Lyon, Rhône, France
  • Eisai Trial Site 4 Freiburg im Breisgau, Baden-Wurttemberg, Germany
View all 39 locations
View Trial Details

Related conditions